These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7635851)

  • 1. Effect of carbamazepine on agitation in Alzheimer's inpatients refractory to neuroleptics.
    Lemke MR
    J Clin Psychiatry; 1995 Aug; 56(8):354-7. PubMed ID: 7635851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics.
    Gleason RP; Schneider LS
    J Clin Psychiatry; 1990 Mar; 51(3):115-8. PubMed ID: 1968457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anticonvulsants in agitation and behavior disorders in demented subjects. Report of 8 cases].
    Fahs H; Potiron G; Senon JL; Perivier E
    Encephale; 1999; 25(2):169-74. PubMed ID: 10370890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic use of carbamazepine for treatment of agitation and affective disorders in geriatric psychiatry patients].
    Lemke MR; Stuhlmann W
    Psychiatr Prax; 1994 Jul; 21(4):147-50. PubMed ID: 7938323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very low-dose neuroleptic treatment in two patients with agitation associated with Alzheimer's disease.
    Risse SC; Lampe TH; Cubberley L
    J Clin Psychiatry; 1987 May; 48(5):207-8. PubMed ID: 2883174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haloperidol versus thioridazine in the treatment of behavioral symptoms in senile dementia of the Alzheimer's type: preliminary findings.
    Steele C; Lucas MJ; Tune L
    J Clin Psychiatry; 1986 Jun; 47(6):310-2. PubMed ID: 3711028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rivastigmine on actigraphically monitored motor activity in severe agitation related to Alzheimer's disease: a placebo-controlled pilot study.
    Mahlberg R; Walther S; Eichmann U; Tracik F; Kunz D
    Arch Gerontol Geriatr; 2007; 45(1):19-26. PubMed ID: 16963137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-neuroleptic treatment of behavioral symptoms and agitation in Alzheimer's disease and other dementia.
    Schneider LS; Sobin PB
    Psychopharmacol Bull; 1992; 28(1):71-9. PubMed ID: 1351687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service.
    Kohen I; Preval H; Southard R; Francis A
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):240-5. PubMed ID: 16503319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of treatment for geropsychiatric patients with severe mental illness.
    Schneider LS
    Psychopharmacol Bull; 1993; 29(4):501-24. PubMed ID: 8084981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose oral haloperidol and blood levels in Alzheimer's disease: a preliminary study.
    Devanand DP; Cooper T; Sackeim HA; Taurke E; Mayeux R
    Psychopharmacol Bull; 1992; 28(2):169-73. PubMed ID: 1513920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose divalproex in agitated patients with Alzheimer's disease.
    Dolder C; McKinsey J
    J Psychiatr Pract; 2010 Jan; 16(1):63-7. PubMed ID: 20098234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.
    Currier GW; Chou JC; Feifel D; Bossie CA; Turkoz I; Mahmoud RA; Gharabawi GM
    J Clin Psychiatry; 2004 Mar; 65(3):386-94. PubMed ID: 15096079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of perospirone on aggressive behavior associated with dementia.
    Sato S; Mizukami K; Moro K; Tanaka Y; Asada T
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):106-9. PubMed ID: 16472367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia.
    Sommer OH; Aga O; Cvancarova M; Olsen IC; Selbaek G; Engedal K
    Dement Geriatr Cogn Disord; 2009; 27(2):155-63. PubMed ID: 19182483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine for treatment-resistant agitation in dementia.
    Lee HB; Hanner JA; Yokley JL; Appleby B; Hurowitz L; Lyketsos CG
    J Geriatr Psychiatry Neurol; 2007 Sep; 20(3):178-82. PubMed ID: 17712102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use and tolerability of fluoxetine in geropsychiatric inpatients.
    Orengo CA; Kunik ME; Molinari V; Workman RH
    J Clin Psychiatry; 1996 Jan; 57(1):12-6. PubMed ID: 8543541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.